ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Cost Analysis of Transoral Surgery versus XRT for Early-Stage Glottic Cancer

by Sue Pondrom • January 10, 2011

  • Tweet
  • Email
Print-Friendly Version

Which treatment for Tis/T1 glottic carcinoma among adult patients, transoral CO2 laser excision (TOL) or external beam radiation (XRT), is superior in terms of cost utility?

You Might Also Like

  • Larynx-Preserving Surgery Associated with Improved Survival in Early-Stage Glottic Cancer
  • Transoral Laser Resection for Early Glottic Cancer
  • Transoral Robotic Surgery, Intensity-Modulated Radiotherapy Offer Comparable Survival Estimates for Early T-Stage Oropharyngeal Cancer
  • Are Patient-Reported Voice Outcomes Better after Surgery or after Radiation for Treatment of T1 Glottic Carcinoma?
Explore This Issue
January 2011

Background: Cancer of the larynx is the most common head and neck cancer, with 75 percent of cases confined to the level of the glottis. The goal of treatment for this highly curable disease is to cure with the best achievable functional result, with no serious complications and in a cost-effective manner.

Study design: Literature review cost-utility analysis

Setting: Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Ontario, Canada

Synopsis: Six head-to-head comparison studies and 22 consecutive case series were identified to examine oncologic control. Primary endpoints were local control (LC), laryngectomy-free survival (LFS) and overall survival (OS). Secondary endpoints were objective and subjective voice quality measures. Several methods were used in cost analysis. The researchers found no significant differences between TOL surgery and XRT with respect to LC, LFS and OS, and no objective differences for voice quality. CO2 laser excision cost $2407.32/case, generating 1.663 quality-adjusted life years (QALYs). Radiation cost $4828.79/case, generating 1.506 QALYs.

Bottom line: There is no clear difference in oncologic outcome between TOL surgery and XRT, but TOL surgery dominates XRT from a cost-utility standpoint.

Citation: Higgins KM. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope. 2011;121:116-134.

—Reviewed by Sue Pondrom

Filed Under: Head and Neck, Literature Reviews Tagged With: cost, head and neck, head and neck cancer, Tis/T1 glottic carcinoma, TOL, XRTIssue: January 2011

You Might Also Like:

  • Larynx-Preserving Surgery Associated with Improved Survival in Early-Stage Glottic Cancer
  • Transoral Laser Resection for Early Glottic Cancer
  • Transoral Robotic Surgery, Intensity-Modulated Radiotherapy Offer Comparable Survival Estimates for Early T-Stage Oropharyngeal Cancer
  • Are Patient-Reported Voice Outcomes Better after Surgery or after Radiation for Treatment of T1 Glottic Carcinoma?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.